0000950170-24-002304.txt : 20240105 0000950170-24-002304.hdr.sgml : 20240105 20240105090939 ACCESSION NUMBER: 0000950170-24-002304 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240105 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240105 DATE AS OF CHANGE: 20240105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Personalis, Inc. CENTRAL INDEX KEY: 0001527753 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 275411038 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38943 FILM NUMBER: 24514593 BUSINESS ADDRESS: STREET 1: 6600 DUMBARTON CIRCLE CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 650-752-1300 MAIL ADDRESS: STREET 1: 6600 DUMBARTON CIRCLE CITY: FREMONT STATE: CA ZIP: 94555 8-K 1 psnl-20240105.htm 8-K 8-K
0001527753false00015277532024-01-052024-01-05

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 5, 2024

 

Personalis, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-38943

27-5411038

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

 

 

 

6600 Dumbarton Circle

Fremont, California

 

94555

(Address of Principal Executive Offices)

 

(Zip Code)

(650) 752-1300

Registrant’s Telephone Number, Including Area Code

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Common Stock, $0.0001 par value per share

 

PSNL

 

The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 2.02 Results of Operations and Financial Condition.

On January 5, 2024, Personalis, Inc. issued a press release announcing its preliminary revenue results for the quarter and fiscal year ended December 31, 2023, and preliminary cash, cash equivalents and short-term investments balance as of December 31, 2023. The full text of the press release is furnished as Exhibit 99.1 to this report on Form 8-K and is incorporated herein by reference.

The information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit

Number

Description

99.1

Press release of Personalis, Inc., dated January 5, 2024.

104

 

Cover Page Interactive Data File (embedded within the inline XBRL document).

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: January 5, 2024

Personalis, Inc.

 

By:

/s/ Aaron Tachibana

Aaron Tachibana

Chief Financial Officer and Chief Operating Officer

 

 

 EX-99.1 2 psnl-ex99_1.htm EX-99.1 EX-99.1

Exhibit 99.1

 

img208356292_0.jpg 

Personalis Reports Preliminary Fourth Quarter and Full

Year 2023 Revenue and Cash Balance

 

FREMONT, CA -- Jan. 5, 2024 -- (BUSINESS WIRE) -- Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported unaudited preliminary revenue for the fourth quarter and full year ended December 31, 2023.

Preliminary Fourth Quarter Revenue and Cash Balance

•
Preliminary total company revenue is estimated to be $19.7 million in the fourth quarter of 2023, an increase of 18% compared with $16.7 million in the fourth quarter of 2022

 

•
Preliminary revenue from pharma tests, enterprise sales, and other customers is estimated to be $18.7 million in the fourth quarter of 2023 compared with $15.8 million in the fourth quarter of 2022; revenue from enterprise customers includes revenue from Natera which is estimated to be $7.1 million in the fourth quarter of 2023, compared with $8.2 million from Natera in the fourth quarter of 2022

 

•
Preliminary revenue from the Veteran’s Administration Million Veteran’s Program (VA MVP) is estimated to be $1.0 million in the fourth quarter of 2023, compared with $0.9 million in the fourth quarter of 2022

 

•
Preliminary cash, cash equivalents, and short-term investments is estimated to be $114.0 million as of December 31, 2023, and is expected to last through the first quarter of 2026, as a result of 2023 cost-cutting measures which reduced expenses by approximately $35 million annually

Preliminary Full Year 2023 Revenue and Cash Usage

•
Preliminary total company revenue is estimated to be $73.5 million in the full year of 2023, an increase of 13% compared with $65.0 million in the full year of 2022

 

•
Preliminary revenue from pharma tests, enterprise sales, and other customers is estimated to be $64.1 million in the full year of 2023 compared with $56.6 million in the full year of 2022; revenue from enterprise customers includes revenue from Natera which is estimated to be $31.7 million in the full year of 2023, compared with $26.6 million from Natera in the full year of 2022

 

•
Preliminary revenue from the VA MVP is estimated to be $9.4 million in the full year of 2023, compared with $8.4 million in the full year of 2022

 

•
Cash usage is expected to be approximately $54 million in the full year of 2023, reduced from $119 million in 2022

“Our strong fourth quarter performance caps off a remarkable year where we delivered on our commitments to investors,” stated Chris Hall, President and CEO of Personalis. “To touch on a few highlights, over this past year we launched our NeXT Personal Dx ultrasensitive MRD product, deepened clinical evidence to support obtaining reimbursement, presented

1

 

 

unprecedented clinical evidence for early-stage lung cancer detection at medical conferences, expanded our relationships with research collaborators, and forged a new strategic commercial partnership with Tempus to commercialize and ramp our MRD product, all while reducing our annualized expenses by $35 million. I’m very proud of our progress and we expect to further leverage our clinical and commercial strength to drive more success in 2024.”

 

The above information is preliminary and subject to Personalis’ normal quarter and year-end accounting procedures and external audit by the company's independent registered public accounting firm. In addition, these preliminary unaudited results are not a comprehensive statement of the company’s financial results for the year ended December 31, 2023, should not be viewed as a substitute for full, audited financial statements prepared in accordance with generally accepted accounting principles, and are not necessarily indicative of the company’s results for any future period.

 

About Personalis, Inc.

At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We aim to drive a new paradigm for cancer management, guiding care from biopsy through the life of the patient. Our highly sensitive assays combine tumor-and-normal profiling with proprietary algorithms to deliver advanced insights even as cancer evolves over time. Our products are designed to detect MRD and recurrence at the earliest timepoints, enable selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development. Personalis is based in Fremont, California. To learn more, visit www.personalis.com and connect with us on LinkedIn and X (Twitter).

Personalis Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts and can generally be identified by terms such as “anticipate,” “estimate,” “expect,” “if,” “may,” “future,” “will” or similar expressions. These statements include statements relating to: Personalis’ preliminary and estimated revenue for the fourth quarter and full year of 2023 and cash position at December 31, 2023, Personalis’ expected cash usage for the full year of 2023, the attributes, advantages or clinical validity of the NeXT Personal Dx test, Personalis’ use of clinical evidence to support obtaining reimbursement, and the expected benefits of Personalis’ collaboration with Tempus. Such forward-looking statements involve known and unknown risks and uncertainties and other factors that may cause actual results to differ materially from any anticipated results or expectations expressed or implied by such statements, including the risks, uncertainties and other factors that relate to the timing and pace of new orders from customers, including from Natera and the VA MVP; the timing of tissue, blood, and other specimen sample receipts from customers, which can materially impact revenue quarter-over-quarter and year-over-year; Personalis’ ability to demonstrate attributes, advantages or clinical validity of the NeXT Personal Dx test, Personalis’ ability to obtain reimbursement, Personalis’ achievement of milestones set forth in the collaboration and co-commercialization agreement with Tempus, the success of Tempus’ sales and marketing efforts, the expected benefits or success of Personalis’ relationships with research collaborators and the adoption and use of the NeXT Personal Dx test by oncologists. These and other potential risks and uncertainties that could cause actual results to differ materially from the results predicted in these forward-looking statements are described under the captions “Risk

2

 

 

Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Personalis’ Annual Report on Form 10-K for the year ended December 31, 2022, filed with the Securities and Exchange Commission (SEC) on February 23, 2023, and its Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, filed with the SEC on November 7, 2023. All information provided in this release is as of the date of this press release, and any forward-looking statements contained herein are based on assumptions that we believe to be reasonable as of this date. Undue reliance should not be placed on the forward-looking statements in this press release, which are based on information available to us on the date hereof. Personalis undertakes no duty to update this information unless required by law.

 

Investors:

Caroline Corner

investors@personalis.com

415-202-5678

 

Media Contact:

pr@personalis.com

3

 

 GRAPHIC 3 img208356292_0.jpg GRAPHIC begin 644 img208356292_0.jpg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end EX-101.SCH 4 psnl-20240105.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.PRE 5 psnl-20240105_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EX-101.LAB 6 psnl-20240105_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Pre-commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Entity Address, State or Province Entity Address, State or Province Trading Symbol Trading Symbol Soliciting Material Soliciting Material Entity Address, City or Town Entity Address, City or Town Written Communications Written Communications Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity Registrant Name Entity Registrant Name Document Period End Date Document Period End Date Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Incorporation, State or Country Code Entity Incorporation State Country Code Local Phone Number Local Phone Number City Area Code City Area Code Pre-commencement Tender Offer Pre Commencement Tender Offer Cover Cover [Abstract] Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Amendment Flag Amendment Flag Entity File Number Entity File Number Entity Address, Address Line One Entity Address, Address Line One Title of 12(b) Security Security 12b Title Document Type Document Type XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.4
Document and Entity Information
Jan. 05, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 05, 2024
Entity Registrant Name Personalis, Inc.
Entity Central Index Key 0001527753
Entity Emerging Growth Company false
Entity File Number 001-38943
Entity Incorporation State Country Code DE
Entity Tax Identification Number 27-5411038
Entity Address, Address Line One 6600 Dumbarton Circle
Entity Address, City or Town Fremont
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94555
City Area Code 650
Local Phone Number 752-1300
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.0001 par value per share
Trading Symbol PSNL
Security Exchange Name NASDAQ
XML 8 psnl-20240105_htm.xml IDEA: XBRL DOCUMENT 0001527753 2024-01-05 2024-01-05 0001527753 false 8-K 2024-01-05 Personalis, Inc. DE 001-38943 27-5411038 6600 Dumbarton Circle Fremont CA 94555 650 752-1300 false false false false Common Stock, $0.0001 par value per share PSNL NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.4 html 1 22 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.personalis.com/20240105/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports psnl-20240105.htm psnl-20240105.xsd psnl-20240105_lab.xml psnl-20240105_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "psnl-20240105.htm": { "nsprefix": "psnl", "nsuri": "http://www.personalis.com/20240105", "dts": { "inline": { "local": [ "psnl-20240105.htm" ] }, "schema": { "local": [ "psnl-20240105.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "psnl-20240105_lab.xml" ] }, "presentationLink": { "local": [ "psnl-20240105_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://www.personalis.com/20240105/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_2316d470-d1e1-412a-94bf-c042c66f9a6f", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "psnl-20240105.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_2316d470-d1e1-412a-94bf-c042c66f9a6f", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "psnl-20240105.htm", "first": true, "unique": true } } }, "tag": { "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.personalis.com/20240105/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "terseLabel": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.personalis.com/20240105/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.personalis.com/20240105/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.personalis.com/20240105/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.personalis.com/20240105/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.personalis.com/20240105/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.personalis.com/20240105/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.personalis.com/20240105/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.personalis.com/20240105/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.personalis.com/20240105/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.personalis.com/20240105/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.personalis.com/20240105/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.personalis.com/20240105/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.personalis.com/20240105/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.personalis.com/20240105/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.personalis.com/20240105/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.personalis.com/20240105/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.personalis.com/20240105/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.personalis.com/20240105/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.personalis.com/20240105/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.personalis.com/20240105/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.personalis.com/20240105/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0000950170-24-002304-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-002304-xbrl.zip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end